Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CleanSpark Inc (CLSK) vs CVS Health Corp (CVS) Price & Performance

CleanSpark IncTrade
CVS Health CorpTrade

Price performance (Past 24H)

Key statistics

CleanSpark Inc vs CVS Health Corp — how do they compare? CleanSpark Inc trades at $11.88 (market cap $2.98B), while CVS Health Corp trades at $93.68 (market cap $122.36B). The key difference: CVS Health Corp is far larger — about 41.1× CleanSpark Inc's market cap, and CVS Health Corp pays a 2.78% dividend while CleanSpark Inc pays none. Which is the better fit depends on your goals.

CLSKCVS
Market Cap
$2.98B$122.36B
Sector
TechnologyHealth
52-Week High
$23.20$110.60
52-Week Low
$8.18$65.51
Enterprise Value
$3.97B$184.71B
Dividend Yield
2.78%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CleanSpark Inc

CleanSpark (CLSK) trades at $12.30, down 3.53% amid a bearish technical outlook despite unanimous analyst buy ratings. The stock faces fundamental challenges with four consecutive quarterly earnings misses and negative profitability margins (-146.9% net income margin). Recent developments include a strategic pivot toward AI data centers, highlighted by a 20-year, $6.6 billion lease agreement in Sandersville, Georgia, which aims to diversify revenue streams beyond Bitcoin mining.

The stock presents a high-risk, high-reward opportunity with analysts projecting 94% upside to a $23.89 consensus target. Key risks include persistent earnings underperformance, negative cash flow from operations, and execution challenges in the AI infrastructure transition. Investors must weigh the long-term potential of the data center pivot against near-term financial volatility and dilution concerns.

CVS Health Corp

CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.

The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CleanSpark Inc

CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.

Read more on CLSK

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS